161 related articles for article (PubMed ID: 5566728)
21. Assays of antagonistic activity of narcotic antagonists in man.
Gorodetzky CW
Adv Biochem Psychopharmacol; 1973; 8(0):291-7. PubMed ID: 4604130
[No Abstract] [Full Text] [Related]
22. Subjective effects of narcotic antagonists.
Haertzen CA
Adv Biochem Psychopharmacol; 1973; 8(0):383-98. PubMed ID: 4795096
[No Abstract] [Full Text] [Related]
23. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
24. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
Wikler A
Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
[No Abstract] [Full Text] [Related]
25. Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.
Martin WR; Jasinski DR; Mansky PA
Arch Gen Psychiatry; 1973 Jun; 28(6):784-91. PubMed ID: 4707988
[No Abstract] [Full Text] [Related]
26. [Morphine withdrawal treatment in 197 admissions for opiates].
Erikson JH
Lakartidningen; 1972 May; 69(22):2657-60. PubMed ID: 5068973
[No Abstract] [Full Text] [Related]
27. Cyclazocine and methadone in narcotic addiction.
Freedman AM; Fink M; Sharoff R; Zaks A
JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
[No Abstract] [Full Text] [Related]
28. Narcotics and medical practice. Medical use of morphine and morphine-like drugs and management of persons dependent on them.
JAMA; 1971 Oct; 218(4):578-83. PubMed ID: 5171009
[No Abstract] [Full Text] [Related]
29. Pharmacological adjuncts in the treatment of opiate dependence.
Resnick RB
Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
[No Abstract] [Full Text] [Related]
30. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
Camarasa X; Khazaal Y; Besson J; Zullino DF
Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
[TBL] [Abstract][Full Text] [Related]
31. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
Jensen GR
Med J Aust; 1973 Apr; 1(16):808-12. PubMed ID: 4707801
[No Abstract] [Full Text] [Related]
32. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
Resnick RB; Schuyten-Resnick E; Washton AM
Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
[No Abstract] [Full Text] [Related]
33. On the treatment of stimulant abuse.
Renault PF; Schuster CR
Perspect Biol Med; 1972; 15(4):561-5. PubMed ID: 5040076
[No Abstract] [Full Text] [Related]
34. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary trials with methadone in the treatment of opiate addictions].
Deniker P; Lôo H; Zarifian E; Cuche H
Ann Med Interne (Paris); 1974 May; 125(5):459-62. PubMed ID: 4440963
[No Abstract] [Full Text] [Related]
36. Narcotic antagonists: new methods to treat heroin addiction.
Hammond AL
Science; 1971 Aug; 173(3996):503-6. PubMed ID: 5564039
[No Abstract] [Full Text] [Related]
37. XXIX. The basis and possible utility of the use of opioid antagonists in the ambulatory treatment of the addict.
Martin WR
Res Publ Assoc Res Nerv Ment Dis; 1968; 46():367-77. PubMed ID: 5723804
[No Abstract] [Full Text] [Related]
38. Narcotic antagonists: the search accelerates.
Maugh TH
Science; 1972 Jul; 177(4045):249-50. PubMed ID: 5041023
[No Abstract] [Full Text] [Related]
39. Animal-human correlates of narcotic dependence: a brief review.
Stimmel B; Glick SD
Am J Psychiatry; 1978 Jul; 135(7):821-5. PubMed ID: 96703
[TBL] [Abstract][Full Text] [Related]
40. Auricular acupuncture in animals: effects of opiate withdrawal and involvement of endorphins.
Ng LK
J Altern Complement Med; 1996; 2(1):61-3; discussion 73-5. PubMed ID: 9395644
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
